Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 1.736
5-Year Impact Factor – 2.135
Index Copernicus  – 168.52
MEiN – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2015, vol. 24, nr 4, July-August, p. 695–703

doi: 10.17219/acem/25212

Publication type: review article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Ovarian Hyperstimulation Caused by Gonadotroph Pituitary Adenoma – Review

Jowita Halupczok1,A,B,C,D, Anna Kluba-Szyszka1,B,D, Bożena Bidzińska-Speichert1,E,F, Bartłomiej Knychalski2,B

1 Department of Endocrinology, Diabetology and Isotope Therapy, Wroclaw Medical University, Poland

2 1st Department of General, Gastroenterological and Endocrinological Surgery, Wroclaw Medical University, Poland

Abstract

Ovarian hyperstimulation syndrome (OHSS) occurs mostly as an iatrogenic complication of assisted reproductive technology. Gonadotroph pituitary adenomas are rarely associated with OHSS. To the authors’ knowledge, to date only 30 cases of spontaneous ovarian stimulation associated with gonadotroph adenomas have been reported in women and only 2 in children. The most common symptoms in such cases included menstrual disturbances, abdominal or pelvic pain, abdominal distension and increased girth. Galactorrhea, nausea and vomiting were also reported. Neurological symptoms occurred when the size of the pituitary tumor reached at least 20 mm. Transvaginal ultrasound examination usually demonstrated enlarged multicystic ovaries. MRIs of the pituitary revealed macroadenomas up to 61 mm in maximum diameter. The hormonal profiles of the reported cases showed normal or elevated FSH levels, suppressed LH levels, elevated estradiol levels and supranormal concentrations of prolactin. Transsphenoidal surgery is the therapy of choice, however other treatment modalities can be utilized in selected cases.

Key words

ovarian hyperstimulation syndrome, pituitary adenoma, menstruation disturbances, gonadotropins.

References (40)

  1. Kumar P, Sait SF, Sharma A, Kumar M: Ovarian hyperstimulation syndrome. J Hum Reprod Sci 2011, 4, 70–75.
  2. Mathur R, Kailasam C, Jenkins J: Review of the evidence base of strategies to prevent ovarian hyperstimulation syndrome. Hum Fertil (Camb) 2007, 10, 75–85.
  3. Elchalal U, Schenker JG: The pathophysiology of ovarian hyperstimulation syndrome – views and ideas. Hum Reprod 1997, 12, 1129–1137.
  4. Abramov Y, Barak V, Nisman B, Schenker JG: Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome. Fertil Steril 1997, 67, 261–265.
  5. Cooper O, Geller JL, Melmed S: Ovarian hyperstimulation syndrome caused by an FSH-secreting pituitary adenoma. Nat Clin Pract Endocrinol Metab 2008, 4, 234–238.
  6. Smits G, Olatunbosun O, Delbaere A, Pierson R, Vassart G, Costagliola S: Ovarian hyperstimulation syndrome due to a mutation in the follicle-stimulating hormone receptor. N Engl J Med 2003, 349, 760–766.
  7. Chaidarun SS, Klibanski A: Gonadotropinomas. Semin Reprod Med 2002, 20, 339–348.
  8. Daneshdoost L, Gennarelli TA, Bashey HM, Savino PJ, Sergott RC, Bosley TM, Snyder PJ: Recognition of gonadotroph adenomas in women. N Engl J Med 1991, 324, 589–594.
  9. Snyder PJ: Gonadotroph cell adenomas of the pituitary. Endocr Rev 1985, 6, 552–563.
  10. Garmes HM, Grassiotto OR, Fernandes YB, Queiroz L de S, Vassalo J, de Oliveira DM, Benneti-Pinto CL: A pituitary adenoma secreting follicle-stimulating hormone with ovarian hyperstimulation: treatment using a gonadotropin-releasing hormone antagonist. Fertil Steril 2012, 97, 231–234.
  11. Arafah BM, Nasrallah MP: Pituitary tumors: pathophysiology, clinical manifestations and management. Endocr Relat Cancer 2001, 8, 287–305.
  12. Kihara M, Sugita T, Nagai Y, Saeki N, Tatsuno I, Seki K: Ovarian hyperstimulation caused by gonadotroph cell adenoma: a case report and review of the literature. Gynecol Endocrinol 2006, 22, 110–113.
  13. Macchia E, Simoncini T, Raffaelli V, Lombardi M, Iannelli A, Martino E: A functioning FSH-secreting pituitary macroadenoma causing an ovarian hyperstimulation syndrome with multiple cysts resected and relapsed after leuprolide in a reproductive-aged woman. Gynecol Endocrinol 2012, 28, 56–59.
  14. Murakami T, Higashitsuji H, Yoshinaga K, Terada Y, Ito K, Ikeda H: Management of ovarian hyperstimulation due to follicle-stimulating hormone-secreting gonadotroph adenoma. BJOG 2004, 111, 1297–1300.
  15. Sicilia V, Earle J, Mezitis SGE: Multiple ovarian cysts and oligomenorrhea as the initial manifestations of a gonadotropin-secreting pituitary macroadenoma. Endocr Pract 2006, 12, 417–421.
  16. Kawaguchi T, Ogawa Y, Ito K, Watanabe M, Tominaga T: Follicle-stimulating hormone-secreting pituitary adenoma manifesting as recurrent ovarian cysts in a young woman – latent risk of unidentified ovarian hyperstimulation: a case report. BMC Res Notes 2013, 6, 408.
  17. Christin-Maitre S, Rongières-Bertrand C, Kottler ML, Lahlou N, Frydman R, Touraine P, Bouchard P: A spontaneous and severe hyperstimulation of the ovaries revealing a gonadotroph adenoma. J Clin Endocrinol Metab 1998, 83, 3450–3453.
  18. Mor E, Rodi IA, Bayrak A, Paulson RJ, Sokol RZ: Diagnosis of pituitary gonadotroph adenomas in reproductiveaged women. Fertil Steril 2005, 84, 757.
  19. Kanaya M, Baba T, Kitajima Y, Ikeda K, Shimizu A, Morishita M, Honnma H, Endo T, Saito T: Continuous follicle-stimulating hormone exposure from pituitary adenoma causes periodic follicle recruitment and atresia, which mimics ovarian hyperstimulation syndrome. Int J Womens Health 2012, 4, 427–431.
  20. Castelbaum AJ, Bigdeli H, Post KD, Freedman MF, Snyder PJ: Exacerbation of ovarian hyperstimulation by leuprolide reveals a gonadotroph adenoma. Fertil Steril 2002, 78, 1311–1313.
  21. Djerassi A, Coutifaris C, West VA, Asa SL, Kapoor SC, Pavlou SN, Snyder PJ: Gonadotroph adenoma in a premenopausal woman secreting follicle-stimulating hormone and causing ovarian hyperstimulation. J Clin Endocrinol Metab 1995, 80, 591–594.
  22. Pentz-Vidovíc I, Skorić T, Grubisić G, Korsíc M, Ivicevic-Bakulic T, Besenski N, Paladino J, Plavsíć V, Zarkovíć K: Evolution of clinical symptoms in a young woman with a recurrent gonadotroph adenoma causing ovarian hyperstimulation. Eur J Endocrinol 2000, 143, 607–614.
  23. Karapanou O, Tzanela M, Tamouridis N, Tsagarakis S: Gonadotroph pituitary macroadenoma inducing ovarian hyperstimulation syndrome: successful response to octreotide therapy. Hormones (Athens) 2012, 11, 199–202.
  24. Lania A, Gangi E, Romoli R, Losa M, Travaglini P, Meringolo D, Ambrosi B, Faglia G, Beck-Peccoz P, Spada A: Impaired estrogen-induced negative feedback on gonadotropin secretion in patients with gonadotropin-secreting and nonfunctioning pituitary adenomas. Eur J Clin Invest 2002, 32, 335–340.
  25. Shimon I, Rubinek T, Bar-Hava I, Nass D, Hadani M, Amsterdam A, Harel G: Ovarian hyperstimulation without elevated serum estradiol associated with pure follicle-stimulating hormone-secreting pituitary adenoma. J Clin Endocrinol Metab 2001, 86, 3635–3640.
  26. Roberts JE, Spandorfer S, Fasouliotis SJ, Lin K, Rosenwaks Z: Spontaneous ovarian hyperstimulation caused by a follicle-stimulating hormone-secreting pituitary adenoma. Fertil Steril 2005, 83, 208–210.
  27. Kajitani T, Liu S, Maruyama T, Uchida H, Sakurai R, Masuda H, Nagashima T, Ono M, Arase T, Yoshimura Y: Analysis of serum FSH bioactivity in a patient with an FSH-secreting pituitary microadenoma and multicystic ovaries: A case report. Hum Reprod 2008, 23, 435–439.
  28. Wide L, Lundberg PO: Hypersecretion of an abnormal form of follicle-stimulating hormone associated with suppressed luteinizing hormone secretion in a woman with a pituitary adenoma. J Clin Endocrinol Metab 1981, 53, 923–930.
  29. Gryngarten MG, Braslavsky D, Ballerini MG, Ledesma J, Ropelato MG, Escobar ME: Spontaneous ovarian hyperstimulation syndrome caused by a follicle-stimulating hormone-secreting pituitary macroadenoma in an early pubertal girl. Horm Res Paediatr 2010, 73, 293–298.
  30. Maruyama T, Masuda H, Uchida H, Nagashima T, Yoshimura Y: Follicle stimulating hormone-secreting pituitary microadenoma with fluctuating levels of ovarian hyperstimulation. Obstet Gynecol 2005, 105, 1215–1218.
  31. Murata Y, Ando H, Nagasaka T, Takahashi I, Saito K, Fukugaki H, Matsuzawa K, Mizutani S: Successful pregnancy after bromocriptine therapy in an anovulatory woman complicated with ovarian hyperstimulation caused by follicle-stimulating hormone-producing plurihormonal pituitary microadenoma. J Clin Endocrinol Metab 2003, 88, 1988–1993.
  32. Chanson P: Adénomes hypophysaires gonadotropes. Ann Endocrinol 2000, 61, 258–268.
  33. Catargi B, Felicie-Dellan E, Tabarin A: Comment on gonadotroph adenoma causing ovarian hyperstimulation. J Clin Endocrinol Metab 1999, 84, 3404.
  34. Välimäki MJ, Tiitinen A, Alfthan H, Paetau A, Poranen A, Sane T, Stenman U: Ovarian hyperstimulation caused by gonadotroph adenoma secreting follicle-stimulating hormone in 28-year-old woman. J Clin Endocrinol Metab 1999, 84, 4204–4208.
  35. Sugita T, Seki K, Nagai Y, Saeki N, Yamaura A, Ohigashi S, Iwata A, Tatsuno I, Sekiya S: Successful pregnancy and delivery after removal of gonadotrope adenoma secreting follicle-stimulating hormone in a 29-year-old amenorrheic woman. Gynecol Obstet Invest 2005, 59, 138–143.
  36. Ghayuri M, Liu JH: Ovarian hyperstimulation syndrome caused by pituitary gonadotroph adenoma secreting follicle-stimulating hormone. Obstet Gynecol 2007, 109, 547–549.
  37. Benito M, Asa SL, Livolsi VA, West VA, Snyder PJ: Gonadotroph tumor associated with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 2005, 90, 570–574.
  38. Tashiro H, Katabuchi H, Ohtake H, Kaku T, Ushio Y, Okamura H: A follicle-stimulating hormone-secreting gonadotroph adenoma with ovarian enlargement in a 10-year-old girl. Fertil Steril 1999, 72, 158–160.
  39. Knoepfelmacher M, Danilovic DLS, Rosa Nasser RHR, Mendonça BB: Effectiveness of treating ovarian hyperstimulation syndrome with cabergoline in two patients with gonadotropin-producing pituitary adenomas. Fertil Steril 2006, 86, 719.e15–18.
  40. Davis A, Goel S, Picolos M, Wang M, Lavis V: Pituitary apoplexy after leuprolide. Pituitary 2006, 9, 263–265.